Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch
Clinical trial NCT02822625 · COMPLETED
Trial details
- NCT number
- NCT02822625
- Sponsor
- Institut de Cancérologie de Lorraine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2019-07-10
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.